On November 12, four scientists from BGI Group were included in the Clarivate 2025 list of Highly Cited Researchers, marking the 11th consecutive year that BGI scientists have been included in the annual list.

The scientists were Academician Huanming Yang, Co-founder and Member of the Board of Directors of BGI Group and Director-General of BGI; Xun Xu, Chief Scientist of BGI Group; Junhua Li, researcher at BGI-Research; and Karsten Kristiansen, expert advisor to BGI Group.

Four scientists from BGI Group were included in the Clarivate 2025 list of Highly Cited Researchers (Image source: Clarivate’s official website).

The 2025 Highly Cited Researchers list uses quantitative metrics and qualitative analysis to identify individuals whose work has had a genuine, global influence on their respective fields. This year’s list includes 6,868 scientists from over 1,300 institutions in 60 countries and regions worldwide. The U.S. leads in the number of scientists selected, followed by Chinese mainland and the UK.

Bar Veinstein, President of Academia & Government at Clarivate, congratulated the scientists on this year's list for “advancing innovation and inspiring the global research community to tackle society’s greatest challenges with creativity and ingenuity.”

Scientific research has been a critical part of BGI Group’s commitment to life sciences. This has included internationally influential scientific achievements based on self-developed multi-omics technologies, including genomics, single-cell omics, and spatiotemporal omics. As of November 13, 2025, BGI has published a total of 5,875 papers, including 865 ‘CNNS’ (the leading academic journals Cell, Nature, New England Journal of Medicine, Science, and their related publications, if any) articles, with 185 published in flagship journals.

BGI Group has also held the leading position in the Nature Index Asia-Pacific biological sciences corporate institutions ranking for a decade, and ranks fourth globally in the 2025 Nature Index annual rankings of research leadership.  

As a global leader in cutting-edge life sciences, BGI Group is committed to a mission of using genomics to benefit mankind through a comprehensive approach that integrates “research, production and application”.